Save time and get answers to complex questions with AI chat
Xiaflex market launch year?Bivalirudin manufacturer?How to apply for vascepa's patient assistance?Campath litigation germany?Patent expiry trametinib?
No known direct drug interactions exist between melatonin and mycophenolate (such as CellCept or Myfortic). Melatonin, a hormone supplement for sleep, does not appear to alter mycophenolate's immunosuppressive effects or blood levels based on standard interaction checkers.[1][2] Mycophenolate inhibits immune cell proliferation, while melatonin has mild immunomodulatory properties but lacks evidence of clinically significant interference at typical doses (e.g., 1-10 mg melatonin nightly).
Mycophenolate users (often post-transplant) should watch for: - Melatonin's subtle immune-boosting effects in high doses (>10 mg), which could theoretically oppose immunosuppression—though studies show no impact on graft rejection.[5] - Gastrointestinal upset: Both can cause nausea; starting low on melatonin minimizes this. - No evidence of altered mycophenolate metabolism via CYP enzymes (melatonin weakly affects 1A2, irrelevant here).[6] Consult your doctor or pharmacist, especially if on other meds like steroids or antivirals.
Guidelines from transplant centers (e.g., Mayo Clinic) allow melatonin for insomnia in immunocompromised patients, citing low risk.[7] A 2022 review in Transplantation found no adverse events in small cohorts using melatonin alongside mycophenolate.[8] Dose melatonin at 0.5-5 mg, 30-60 minutes before bed.
Other Questions About Melatonin :